{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:25:38Z","timestamp":1790767538541,"version":"4.1.0"},"reference-count":260,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013383","name":"Instituto Nacional de Ci\u00eancia e Tecnologia: F\u00edsica Nuclear e Aplica\u00e7\u00f5es","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013383","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2024\/05678-0"],"award-info":[{"award-number":["2024\/05678-0"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2024\/18425-2"],"award-info":[{"award-number":["2024\/18425-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["465687\/2014-8"],"award-info":[{"award-number":["465687\/2014-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2022\/01969-4"],"award-info":[{"award-number":["2022\/01969-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.840590\/2023-00"],"award-info":[{"award-number":["88887.840590\/2023-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/50928-2"],"award-info":[{"award-number":["2014\/50928-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioadv.2025.214625","type":"journal-article","created":{"date-parts":[[2025,11,23]],"date-time":"2025-11-23T22:52:25Z","timestamp":1763938345000},"page":"214625","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy"],"prefix":"10.1016","volume":"180","author":[{"given":"Ana Vitoria Pupo","family":"Silvestrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ualisson Jos\u00e9","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena Finazzi","family":"Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Vieira","family":"Depieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vit\u00f3ria Lopes Badra","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2025.214625_bb0005","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1111\/bjd.13854","article-title":"The global challenge for skin health","volume":"172","author":"Hay","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0010","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1001\/jamadermatol.2016.5538","article-title":"Global skin disease morbidity and mortality","volume":"153","author":"Karimkhani","year":"2017","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0015","article-title":"The burden of skin and subcutaneous diseases: findings from the global burden of disease study 2019","volume":"11","author":"Yakupu","year":"2023","journal-title":"Front. Public Heal."},{"key":"10.1016\/j.bioadv.2025.214625_bb0020","series-title":"Global Report on Psoriasis","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.bioadv.2025.214625_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0030","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.bioadv.2025.214625_bb0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","article-title":"Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030","volume":"316","author":"Wang","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0040","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/bjd.19169","article-title":"Systematic review examining changes over time and variation in the incidence and prevalence of psoriasis by age and gender","volume":"184","author":"Iskandar","year":"2021","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0045","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases","volume":"76","author":"Takeshita","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2025.214625_bb0055","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/bjd.15021","article-title":"Incidence, prevalence and mortality of patients with psoriasis: a U.K. population-based cohort study","volume":"176","author":"Springate","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0060","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1111\/exd.14841","article-title":"A narrative review of the socioeconomic burden associated with generalised pustular psoriasis","volume":"32","author":"Zimmermann","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0065","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/bjd\/ljae217","article-title":"Prevalence, incidence, mortality and healthcare resource use for generalized pustular psoriasis, palmoplantar pustulosis and plaque psoriasis in England: a population-based cohort study","volume":"191","author":"Frysz","year":"2024","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0070","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jaad.2010.11.055","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis","volume":"65","author":"Menter","year":"2011","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0075","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaad.2008.06.043","article-title":"The impact of psoriasis on health care costs and patient work loss","volume":"59","author":"Fowler","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0080","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2165\/11591580-000000000-00000","article-title":"The burden of moderate to severe psoriasis","volume":"30","author":"Raho","year":"2012","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bioadv.2025.214625_bb0085","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.bioadv.2025.214625_bb0090","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2025.214625_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41578-021-00405-w","article-title":"Clinical translation of long-acting drug delivery formulations","volume":"7","author":"Li","year":"2022","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.bioadv.2025.214625_bb0100","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioadv.2025.214625_bb0105","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41565-022-01174-5","article-title":"Nanotechnology-based strategies against SARS-CoV-2 variants","volume":"17","author":"Huang","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btm2.10143","article-title":"Nanoparticles in the clinic: an update","volume":"4","author":"Anselmo","year":"2019","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jconrel.2021.12.030","article-title":"Evolution of drug delivery systems: from 1950 to 2020 and beyond","volume":"342","author":"Park","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb0120","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/s41565-021-00866-8","article-title":"Nanotechnology approaches for global infectious diseases","volume":"16","author":"Kirtane","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioadv.2022.212726","article-title":"Immunotherapeutic nanoparticles: from autoimmune disease control to the development of vaccines","volume":"135","author":"Mitarotonda","year":"2022","journal-title":"Biomater. Adv."},{"key":"10.1016\/j.bioadv.2025.214625_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202107960","article-title":"Nanocarriers for skin applications: where do we stand?","volume":"61","author":"Tiwari","year":"2022","journal-title":"Angew. Chemie Int. Ed."},{"key":"10.1016\/j.bioadv.2025.214625_bb0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/s44222-023-00141-6","article-title":"Microneedle biomedical devices","volume":"2","author":"Zheng","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.bioadv.2025.214625_bb0140","article-title":"Psoriasis","volume":"2","author":"Greb","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.bioadv.2025.214625_bb0145","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.clindermatol.2007.08.003","article-title":"The clinical spectrum of psoriasis","volume":"25","author":"Naldi","year":"2007","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0150","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/PTT.S101232","article-title":"Erythrodermic psoriasis: pathophysiology and current treatment perspectives","volume":"6","author":"Liao","year":"2016","journal-title":"Psoriasis Targets Ther."},{"key":"10.1016\/j.bioadv.2025.214625_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00403-024-03051-8","article-title":"Antistreptococcal treatment of psoriasis: a systematic review","volume":"316","author":"Sitton","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0160","article-title":"Antistreptococcal interventions for guttate and chronic plaque psoriasis","volume":"2019","author":"Dupire","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0165","doi-asserted-by":"crossref","first-page":"953","DOI":"10.2147\/CCID.S189000","article-title":"Inverse psoriasis: from diagnosis to current treatment options","volume":"12","author":"Micali","year":"2019","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clindermatol.2016.09.004","article-title":"Palmoplantar psoriasis","volume":"35","author":"Engin","year":"2017","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0175","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jdv.14949","article-title":"Generalized pustular psoriasis: a review and update on treatment","volume":"32","author":"Hoegler","year":"2018","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0180","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/exd.14768","article-title":"Pathophysiology of generalized pustular psoriasis","volume":"32","author":"Young","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0185","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41423-020-0519-3","article-title":"\u201cAutoinflammatory psoriasis\u201d\u2014genetics and biology of pustular psoriasis","volume":"18","author":"Uppala","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0190","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/11597000-000000000-00000","article-title":"Nail Psoriasis","volume":"13","author":"Tan","year":"2012","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0195","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1468-3083.2009.03364.x","article-title":"Approach to managing patients with nail psoriasis","volume":"23","author":"Reich","year":"2009","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2024.1385491","article-title":"Differential risks of psoriatic arthritis development in patients with varied psoriasis manifestations: a sex- and ethnicity-specific analysis","volume":"11","author":"Gershater","year":"2024","journal-title":"Front. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0205","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00296-013-2876-z","article-title":"High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional study","volume":"34","author":"Henes","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bioadv.2025.214625_bb0210","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0140-6736(18)30830-4","article-title":"The pathogenesis of psoriatic arthritis","volume":"391","author":"Veale","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.bioadv.2025.214625_bb0215","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/j.bioadv.2025.214625_bb0220","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/archderm.143.12.1493","article-title":"The risk of mortality in patients with psoriasis","volume":"143","author":"Gelfand","year":"2007","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0225","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s13555-023-00986-0","article-title":"The prevalent Comorbidome at the onset of psoriasis diagnosis","volume":"13","author":"Buja","year":"2023","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.bioadv.2025.214625_bb0230","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/jdv.19901","article-title":"Generalized pustular psoriasis: a nationwide population-based study using the National Health Data System in France","volume":"38","author":"Viguier","year":"2024","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0235","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/1346-8138.13841","article-title":"Internalized stigma in psoriasis: a multicenter study","volume":"44","author":"Alpsoy","year":"2017","journal-title":"J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0240","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jpsychires.2024.06.024","article-title":"Prevalence of anxiety, depression, sleeping problems, cognitive impairment, and suicidal ideation in people with autoimmune skin diseases","volume":"176","author":"Jia","year":"2024","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0245","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/jid.2013.508","article-title":"The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and Meta-analysis","volume":"134","author":"Dowlatshahi","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jaad.2017.05.019","article-title":"Psoriasis and suicidality: a systematic review and meta-analysis","volume":"77","author":"Singh","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0255","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1186\/s12889-019-7775-0","article-title":"The psychosocial adaptation of patients with skin disease: a scoping review","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bioadv.2025.214625_bb0260","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbi.2023.12.005","article-title":"Role of stress in skin diseases: a neuroendocrine-immune interaction view","volume":"116","author":"Zhang","year":"2024","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bioadv.2025.214625_bb0265","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0270","first-page":"1","article-title":"Psoriasis increased the risk of adverse cardiovascular outcomes: a new systematic review and Meta-analysis of cohort study","volume":"9","author":"Liu","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0275","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jaad.2020.10.031","article-title":"Trends in mortality and cause-specific mortality among patients with psoriasis and psoriatic arthritis in Ontario, Canada","volume":"84","author":"Colaco","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0280","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.2007.08068.x","article-title":"Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review","volume":"157","author":"W. Sterry, B.E. Strober, A. Menter, on behalf of the I.P. Council","year":"2007","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0285","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0290","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jaad.2021.03.023","article-title":"Psoriasis in liver disease: associations beyond nonalcoholic fatty liver disease","volume":"86","author":"Yang","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0295","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00296-024-05760-9","article-title":"Increase in comorbidities with age among patients with psoriatic arthritis: a multicenter observational study","volume":"45","author":"Chandrashekara","year":"2025","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bioadv.2025.214625_bb0300","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1001\/jamadermatol.2021.4918","article-title":"Association of Psoriasis with Incident Venous Thromboembolism and Peripheral Vascular Disease","volume":"158","author":"Chen","year":"2022","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0305","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s10067-022-06484-6","article-title":"Autonomic dysfunction and cardiovascular risk in psoriatic arthritis","volume":"42","author":"Gezer","year":"2023","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0310","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1097\/MIB.0000000000001169","article-title":"Prevalence and phenotype of concurrent psoriasis and inflammatory bowel disease","volume":"23","author":"Eppinga","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bioadv.2025.214625_bb0315","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/annrheumdis-2012-202143","article-title":"Psoriasis, psoriaticarthritis and increased risk of incident Crohn\u2019s disease in US women","volume":"72","author":"Li","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioadv.2025.214625_bb0320","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of Psoriasis with Inflammatory Bowel Disease","volume":"154","author":"Fu","year":"2018","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0325","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bjd.14528","article-title":"Association between psoriasis and inflammatory bowel disease: a Danish nationwide cohort study","volume":"175","author":"Egeberg","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0330","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/ecco-jcc\/jjz152","article-title":"Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease\u2014a systematic review and Meta-analysis","volume":"14","author":"Alinaghi","year":"2020","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bioadv.2025.214625_bb0335","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajhg.2012.02.020","article-title":"Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci","volume":"90","author":"Ellinghaus","year":"2012","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bioadv.2025.214625_bb0340","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamadermatol.2020.0024","article-title":"Prevalence, incidence, and risk of cancer in patients with psoriasis and psoriatic arthritis","volume":"156","author":"Vaengebjerg","year":"2020","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0345","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jdv.12165","article-title":"Risk of cancer in psoriasis: a systematic review and meta-analysis of epidemiological studies","volume":"27","author":"Pouplard","year":"2013","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0350","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jamadermatol.2019.3056","article-title":"Association of Psoriasis with the risk of developing or dying of Cancer: a systematic review and Meta-analysis","volume":"155","author":"Trafford","year":"2019","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0355","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15382","article-title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","volume":"8","author":"Tsoi","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2025.214625_bb0360","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: a comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.bioadv.2025.214625_bb0365","first-page":"310","article-title":"Characteristics and pathogenesis of Koebner phenomenon","author":"Zhang","year":"2022","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0370","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/PTT.S126727","article-title":"Drug-induced psoriasis: clinical perspectives","volume":"7","author":"Balak","year":"2017","journal-title":"Psoriasis Targets Ther."},{"key":"10.1016\/j.bioadv.2025.214625_bb0375","first-page":"1","article-title":"Type1 interferons potential initiating factors linking skin wounds with psoriasis pathogenesis","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0380","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","article-title":"The immunology of psoriasis\u2014current concepts in pathogenesis","volume":"66","author":"Sieminska","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bioadv.2025.214625_bb0385","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0390","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: a comprehensive review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.bioadv.2025.214625_bb0395","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.4049\/jimmunol.181.7.4733","article-title":"Induction of IL-17+ T cell trafficking and development by IFN-\u03b3: mechanism and pathological relevance in psoriasis","volume":"181","author":"Kryczek","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0400","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jid.2016.11.033","article-title":"Dynamic changes in resident and infiltrating epidermal dendritic cells in active and resolved psoriasis","volume":"137","author":"Martini","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0405","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1038\/jid.2014.98","article-title":"IL-23 from Langerhans cells is required for the development of Imiquimod-induced psoriasis-like dermatitis by induction of IL-17A-producing \u03b3\u03b4 T cells","volume":"134","author":"Yoshiki","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0410","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jdermsci.2011.11.007","article-title":"Chemokine receptors in the pathogenesis and therapy of psoriasis","volume":"65","author":"Mabuchi","year":"2012","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb0415","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1038\/jid.2009.65","article-title":"Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis","volume":"129","author":"Harper","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0420","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bioadv.2025.214625_bb0425","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.4049\/jimmunol.1201505","article-title":"Keratinocyte overexpression of IL-17C promotes Psoriasiform skin inflammation","volume":"190","author":"Johnston","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0430","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature05505","article-title":"Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis","volume":"445","author":"Zheng","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bioadv.2025.214625_bb0435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.3007828","article-title":"Human T H 9 cells are skin-tropic and have autocrine and paracrine Proinflammatory capacity","volume":"6","author":"Schlapbach","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0440","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1172\/JCI93396","article-title":"Clinically resolved psoriatic lesions contain psoriasis-specific IL-17\u2013producing \u03b1\u03b2 T cell clones","volume":"127","author":"Matos","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioadv.2025.214625_bb0445","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1080\/10715762.2019.1648800","article-title":"Oxidative stress involvement in psoriasis: a systematic review","volume":"53","author":"Cannav\u00f2","year":"2019","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0450","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36\u2013receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0455","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2019.02.004","article-title":"Chronopharmacology of glucocorticoids","volume":"151\u2013152","author":"Scherholz","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0460","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1468-3083.2009.03358.x","article-title":"Topical corticosteroids in psoriasis: strategies for improving safety","volume":"24","author":"Horn","year":"2010","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0470","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2012.04522.x","article-title":"Topical corticosteroids in plaque psoriasis: a systematic review of efficacy and treatment modalities","volume":"26","author":"Castela","year":"2012","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0475","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.mam.2008.04.001","article-title":"Vitamin D analogs: therapeutic applications and mechanisms for selectivity","volume":"29","author":"Brown","year":"2008","journal-title":"Mol. Aspects Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102695","article-title":"Vitamin D: a master example of nutrigenomics","volume":"62","author":"Carlberg","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0485","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.drudis.2014.06.008","article-title":"Pharmacological effects of vitamin D and its analogs: recent developments","volume":"19","author":"Sintov","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214625_bb0490","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1067\/mjd.2002.120942","article-title":"Tacrolimus and pimecrolimus: from clever prokaryotes to inhibiting calcineurin and treating atopic dermatitis","volume":"46","author":"Nghiem","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2022.119366","article-title":"A cellular atlas of calcineurin signaling","volume":"1870","author":"Ulengin-Talkish","year":"2023","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0500","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies","volume":"60","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13555-015-0068-3","article-title":"Keratolytics and emollients and their role in the therapy of psoriasis: a systematic review","volume":"5","author":"Jacobi","year":"2015","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.bioadv.2025.214625_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107784","article-title":"A deep dive into UV-based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer","volume":"222","author":"Vieyra-Garcia","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioadv.2025.214625_bb0515","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.det.2019.08.004","article-title":"How it works","volume":"38","author":"Yu","year":"2020","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.bioadv.2025.214625_bb0520","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaad.2020.04.095","article-title":"Role of phototherapy in the era of biologics","volume":"84","author":"Torres","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0525","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10103-017-2360-1","article-title":"A clinical review of phototherapy for psoriasis","volume":"33","author":"Zhang","year":"2018","journal-title":"Lasers Med. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb0530","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.det.2019.08.009","article-title":"Beyond the booth: excimer laser for cutaneous conditions","volume":"38","author":"Ly","year":"2020","journal-title":"Dermatol. Clin."},{"key":"10.1016\/j.bioadv.2025.214625_bb0535","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nrrheum.2010.5","article-title":"Methotrexate\u2014how does it really work?","volume":"6","author":"Chan","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0540","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1468-3083.2000.00058.x","article-title":"Methotrexate in psoriasis: 26 years\u2019 experience with low-dose long-term treatment","volume":"14","author":"Haustein","year":"2000","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0545","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0550","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00403-024-03425-y","article-title":"Clinical features and effects of cyclosporine in the treatment of psoriasis: a systemic review and meta-analysis","volume":"316","author":"Li","year":"2024","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.annder.2024.103287","article-title":"Treatment of moderate-to-severe psoriasis in adults: an expert consensus statement using a Delphi method to produce a decision-making algorithm","volume":"151","author":"Poizeau","year":"2024","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0560","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaad.2009.05.017","article-title":"Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference","volume":"62","author":"Rosmarin","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0565","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1067\/mjd.2001.116347","article-title":"Consensus conference: Acitretin in combination with UVB or PUVA in the treatment of psoriasis","volume":"45","author":"Lebwohl","year":"2001","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0570","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/dth.12086","article-title":"Acitretin","volume":"26","author":"Ortiz","year":"2013","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.bioadv.2025.214625_bb0575","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1194\/jlr.R030833","article-title":"Vitamin a and retinoid signaling: genomic and nongenomic effects","volume":"54","author":"Al Tanoury","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0580","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor superfamily: a structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb0585","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1517\/14656566.6.10.1725","article-title":"A review of acitretin, a systemic retinoid for the treatment of psoriasis","volume":"6","author":"Sue Lee","year":"2005","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bioadv.2025.214625_bb0590","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2147\/PTT.S51490","article-title":"Fumaric acid esters in the management of psoriasis","volume":"5","author":"Balak","year":"2015","journal-title":"Psoriasis Targets Ther."},{"key":"10.1016\/j.bioadv.2025.214625_bb0595","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.15218","article-title":"Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus","volume":"32","author":"Mrowietz","year":"2018","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0600","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/bjd.14676","article-title":"Oral fumaric acid esters for psoriasis: abridged Cochrane systematic review including GRADE assessments","volume":"175","author":"Atwan","year":"2016","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0605","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s13555-022-00863-2","article-title":"Efficacy and safety of dimethyl fumarate in patients with moderate-to-severe plaque psoriasis: results from a 52-week open-label phase IV clinical trial (DIMESKIN 1)","volume":"13","author":"Daud\u00e9n","year":"2023","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.bioadv.2025.214625_bb0610","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/14740338.2020.1736553","article-title":"A safety evaluation of dimethyl fumarate in moderate-to-severe psoriasis","volume":"19","author":"Reszke","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bioadv.2025.214625_bb0615","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.jaad.2023.11.068","article-title":"Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 16-week results from SPROUT, a randomized controlled trial","volume":"90","author":"Fiorillo","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0620","first-page":"1","article-title":"The efficacy and safety of non-biologic and biologic treatments in palmoplantar pustular psoriasis and palmoplantar Pustulosis: a systematic review and network Meta-analysis","author":"Alshareef","year":"2025","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0625","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","article-title":"Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: results of 2 phase III randomized, controlled trials (ESTEEM 1 and ESTEEM 2)","volume":"74","author":"Rich","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0630","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pharmthera.2005.07.003","article-title":"Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents","volume":"109","author":"Lugnier","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioadv.2025.214625_bb0635","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1210\/er.2013-1053","article-title":"Clinical and molecular genetics of the Phosphodiesterases (PDEs)","volume":"35","author":"Azevedo","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0640","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/bjd.14164","article-title":"Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: a phase III, randomized controlled trial (ESTEEM 2)","volume":"173","author":"Paul","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0645","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41584-024-01153-1","article-title":"JAK inhibitor selectivity: new opportunities, better drugs?","volume":"20","author":"Virtanen","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0650","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.2147\/CCID.S433367","article-title":"JAK inhibitors in psoriatic disease","volume":"16","author":"Megna","year":"2023","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0655","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ard.2025.01.024","article-title":"Safety of Janus kinase inhibitors in immune-mediated inflammatory diseases \u2013 a systematic literature review informing the 2024 update of an international expert consensus statement","volume":"84","author":"Konzett","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bioadv.2025.214625_bb0660","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jamadermatol.2024.4688","article-title":"Safety and efficacy of Deucravacitinib in moderate to severe plaque psoriasis for up to 3 years","volume":"161","author":"Armstrong","year":"2025","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0665","volume":"1","author":"Ghilardi","year":"2020","journal-title":"30 Years of Biotherapeutics Development \u2014 What Have We Learned\u00a0?"},{"key":"10.1016\/j.bioadv.2025.214625_bb0670","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0675","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev-med-042915-103905","article-title":"Highly effective new treatments for psoriasis target the IL-23\/type 17 T cell autoimmune Axis","volume":"68","author":"Kim","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0680","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa2102383","article-title":"Bimekizumab versus Secukinumab in Plaque Psoriasis","volume":"385","author":"Reich","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0685","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2111563","article-title":"Trial of Spesolimab for generalized pustular psoriasis","volume":"385","author":"Bachelez","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0690","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/1346-8138.14096","article-title":"Safety of biologics in psoriasis","volume":"45","author":"Kamata","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0695","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1600-0625.2008.00786.x","article-title":"The skin: an indispensable barrier","volume":"17","author":"Proksch","year":"2008","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0700","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101252","article-title":"The skin barrier: an extraordinary interface with an exceptional lipid organization","volume":"92","author":"Bouwstra","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109212","article-title":"Lipidomic profiling reveals metabolic signatures in psoriatic skin lesions","volume":"246","author":"Liu","year":"2023","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0710","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/exd.14895","article-title":"Altered structure indicating reduced barrier function of lesional compared to non-lesional psoriatic skin\u2014a non-invasive in vivo study of the human stratum corneum with confocal Raman micro-spectroscopy","volume":"32","author":"Zolotas","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.pacs.2024.100611","article-title":"Photoacoustics structural and functional imaging of psoriasis for severity assessment and quantitative monitoring of treatment response using high-resolution optoacoustic imaging","volume":"38","author":"Li","year":"2024","journal-title":"Photoacoustics"},{"key":"10.1016\/j.bioadv.2025.214625_bb0720","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/1346-8138.16003","article-title":"Possible role of epiregulin from dermal fibroblasts in the keratinocyte hyperproliferation of psoriasis","volume":"48","author":"Iwata","year":"2021","journal-title":"J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0725","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jid.2019.01.014","article-title":"IL-17 and IL-22 promote keratinocyte Stemness in the Germinative compartment in psoriasis","volume":"139","author":"Ekman","year":"2019","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0730","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40246-018-0158-2","article-title":"Mutational analysis of epidermal and hyperproliferative type I keratins in mild and moderate psoriasis vulgaris patients: a possible role in the pathogenesis of psoriasis along with disease severity","volume":"12","author":"Elango","year":"2018","journal-title":"Hum. Genomics"},{"key":"10.1016\/j.bioadv.2025.214625_bb0735","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/jid.2011.24","article-title":"TNF-\u03b1 downregulates Filaggrin and Loricrin through c-Jun N-terminal kinase: role for TNF-\u03b1 antagonists to improve skin barrier","volume":"131","author":"Kim","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0740","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.0022-202X.2005.23762.x","article-title":"Amphiregulin causes functional downregulation of Adherens junctions in psoriasis","volume":"124","author":"Chung","year":"2005","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0745","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-2133.2008.08578.x","article-title":"Alterations in the desquamation-related proteolytic cleavage of corneodesmosin and other corneodesmosomal proteins in psoriatic lesional epidermis","volume":"159","author":"Simon","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0750","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1111\/jdv.12736","article-title":"Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin","volume":"29","author":"Visconti","year":"2015","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2024.100257","article-title":"The interplay between epidermal barrier distribution, microbiota composition, and immune infiltrate defines and stratifies psoriasis patients and is associated with disease severity","volume":"9","author":"Ortega Rocha","year":"2024","journal-title":"J. Transl. Autoimmun."},{"key":"10.1016\/j.bioadv.2025.214625_bb0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113929","article-title":"Topical drug delivery: history, percutaneous absorption, and product development","volume":"177","author":"Roberts","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0765","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0770","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115198","article-title":"Nanotechnology strategies to address challenges in topical and cellular delivery of siRNAs in skin disease therapy","volume":"207","author":"Silvestrini","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0775","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1080\/17425247.2020.1819979","article-title":"Advances in lyotropic liquid crystal systems for skin drug delivery","volume":"17","author":"Silvestrini","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioadv.2025.214625_bb0780","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.xphs.2016.10.001","article-title":"Recent advances in lipid-based vesicles and particulate carriers for topical and transdermal application","volume":"106","author":"Jain","year":"2017","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb0785","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijbiomac.2022.05.156","article-title":"Smart active-targeting of lipid-polymer hybrid nanoparticles for therapeutic applications: recent advances and challenges","volume":"213","author":"Khalili","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0790","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.addr.2020.06.020","article-title":"Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles","volume":"156","author":"Luther","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0795","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.bbamem.2009.04.002","article-title":"The role of fatty acid unsaturation in minimizing biophysical changes on the structure and local effects of bilayer membranes","volume":"1788","author":"Leekumjorn","year":"2009","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.bioadv.2025.214625_bb0800","first-page":"1","article-title":"Nanoparticle skin penetration: depths and routes modeled in-silico","volume":"2412541","author":"Maeda","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2025.214625_bb0805","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ijpharm.2009.07.038","article-title":"Study on the mechanisms of chitosan and its derivatives used as transdermal penetration enhancers","volume":"382","author":"He","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214625_bb0810","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2023.12.026","article-title":"Self-assembled hyaluronic acid nanoparticles for the topical treatment of inflammatory skin diseases: beyond drug carriers","volume":"366","author":"Lee","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2025.123604","article-title":"Emerging trends in chitosan based colloidal drug delivery systems: a translational journey from research to practice","volume":"360","author":"Manohar","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2025.214625_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121027","article-title":"Topical cationic hairy particles targeting cell free DNA in dermis enhance treatment of psoriasis","volume":"276","author":"Yan","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214625_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abb5274","article-title":"Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys","volume":"6","author":"Liang","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioadv.2025.214625_bb0830","doi-asserted-by":"crossref","DOI":"10.1038\/srep16908","article-title":"Shape-dependent skin penetration of silver nanoparticles: does it really matter?","volume":"5","author":"Tak","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2025.214625_bb0835","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/smll.201401913","article-title":"Interactions of skin with gold nanoparticles of different surface charge, shape, and functionality","volume":"11","author":"Fernandes","year":"2015","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2025.214625_bb0840","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-42047-7","article-title":"Preferential accumulation of phospholipid-PEG and Cholesterol-PEG decorated gold Nanorods into human skin layers and their Photothermal-based antibacterial activity","volume":"9","author":"Mahmoud","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2025.214625_bb0845","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jconrel.2022.09.025","article-title":"Overcoming skin barriers through advanced transdermal drug delivery approaches","volume":"351","author":"Phatale","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb0850","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijpharm.2013.02.040","article-title":"Skin penetration enhancers","volume":"447","author":"Lane","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214625_bb0855","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1021\/bm300545b","article-title":"Effect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetration","volume":"13","author":"Yang","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bioadv.2025.214625_bb0860","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2019.06.005","article-title":"Crossing biological barriers with nanogels to improve drug delivery performance","volume":"307","author":"Cuggino","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115119","article-title":"Emerging drug delivery systems with traditional routes \u2013 a roadmap to chronic inflammatory diseases","volume":"203","author":"Min","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.127442","article-title":"Unveiling the behavior of cubic and reverse hexagonal liquid crystalline nanoparticles in cellular and skin delivery of glucocorticoid and small interfering RNA","volume":"427","author":"Silvestrini","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioadv.2025.214625_bb0875","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt1193","article-title":"Transdermal protein delivery by a coadministered peptide identified via phage display","volume":"24","author":"Chen","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0880","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1208\/s12249-022-02424-4","article-title":"Cell-penetrating peptides as passive permeation enhancers for transdermal drug delivery","volume":"23","author":"Chablani","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2025.214625_bb0885","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2014.12.006","article-title":"Peptides as skin penetration enhancers: mechanisms of action","volume":"199","author":"Kumar","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb0890","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1248\/cpb.59.196","article-title":"Development of an efficient transdermal delivery system of small interfering RNA using functional peptides, tat and AT-1002","volume":"59","author":"Uchida","year":"2011","journal-title":"Chem. Pharm. Bull."},{"key":"10.1016\/j.bioadv.2025.214625_bb0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115139","article-title":"Peptide-containing nanoformulations: skin barrier penetration and activity contribution","volume":"203","author":"Zhang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0900","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.addr.2021.02.008","article-title":"Target specific tight junction modulators","volume":"171","author":"Brunner","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb0905","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102638","article-title":"Strategies for improving the safety and RNAi efficacy of noncovalent peptide\/siRNA nanocomplexes","volume":"302","author":"Wang","year":"2022","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb0910","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12272-022-01425-y","article-title":"Recent advances in selective and targeted drug\/gene delivery systems using cell-penetrating peptides","volume":"46","author":"Nam","year":"2023","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0915","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s12951-024-02552-y","article-title":"Deep eutectic solvent self-assembled reverse nanomicelles for transdermal delivery of sparingly soluble drugs","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.bioadv.2025.214625_bb0920","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.actbio.2020.08.020","article-title":"Multi-component clobetasol-loaded monolithic lipid-polymer hybrid nanoparticles ameliorate imiquimod-induced psoriasis-like skin inflammation in Swiss albino mice","volume":"115","author":"Pukale","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2025.214625_bb0925","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejps.2016.09.007","article-title":"Comparative anti-psoriatic efficacy studies of clobetasol loaded chitin nanogel and marketed cream","volume":"96","author":"Panonnummal","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb0930","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17425247.2017.1264386","article-title":"Solid lipid nanoparticles and nanostructured lipid carrier-based nanotherapeutics in treatment of psoriasis: a comparative study","volume":"14","author":"Arora","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.bioadv.2025.214625_bb0935","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1080\/08982104.2019.1593449","article-title":"Preparation, characterization, and in vivo evaluation of cyclosporine cationic liposomes for the treatment of psoriasis","volume":"30","author":"Walunj","year":"2020","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb0940","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamadermatol.2016.0859","article-title":"Efficacy of novel topical liposomal formulation of cyclosporine in mild to moderate stable plaque psoriasis","volume":"152","author":"Kumar","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0945","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2019.03.042","article-title":"Comparative assessment of efficacy and safety potential of multifarious lipid based tacrolimus loaded nanoformulations","volume":"562","author":"Jain","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214625_bb0950","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s13555-024-01102-6","article-title":"Efficacy and safety of topical tacrolimus microemulsion applied twice daily in patients with mild to moderate scalp psoriasis","volume":"14","author":"Pinter","year":"2024","journal-title":"Dermatol. Ther. (Heidelb.)"},{"key":"10.1016\/j.bioadv.2025.214625_bb0955","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1208\/s12249-021-02116-5","article-title":"Topical application of vitamin D3-loaded hybrid Nanosystem to offset Imiquimod-induced psoriasis","volume":"22","author":"Pukale","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2025.214625_bb0960","doi-asserted-by":"crossref","first-page":"14859","DOI":"10.1021\/acsami.1c19180","article-title":"Skin-permeable Nano-Lithocholic Lipidoid efficiently alleviates psoriasis-like chronic skin inflammations","volume":"14","author":"Rachamalla","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2025.214625_bb0965","article-title":"Nano transdermal system combining mitochondria-targeting cerium oxide nanoparticles with all-trans retinoic acid for psoriasis","volume":"18","author":"Wang","year":"2023","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb0970","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2147\/IJN.S156412","article-title":"Pivotal role of Acitretin nanovesicular gel for effective treatment of psoriasis: ex vivo–in vivo evaluation study","volume":"13","author":"Abu Hashim","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214625_bb0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118556","article-title":"Novel antipsoriatic fluidized spanlastic nanovesicles: in vitro physicochemical characterization, ex vivo cutaneous retention and exploratory clinical therapeutic efficacy","volume":"568","author":"Elmowafy","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214625_bb0980","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.jid.2019.09.018","article-title":"Nanoparticle-coupled topical methotrexate can normalize immune responses and induce tissue remodeling in psoriasis","volume":"140","author":"\u00d6zcan","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb0985","first-page":"276","article-title":"Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model, nanomedicine nanotechnology","volume":"17","author":"Fratoddi","year":"2019","journal-title":"Biol. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb0990","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioadv.2025.214625_bb0995","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s10787-023-01178-0","article-title":"Review of natural compounds for potential psoriasis treatment","volume":"31","author":"Elkhawaga","year":"2023","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bioadv.2025.214625_bb1000","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123373","article-title":"Mesoporous silica-based nanocarriers with dual response to pH and ROS for enhanced anti-inflammation therapy of 5-demethylnobiletin against psoriasis-like lesions","volume":"645","author":"Wang","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214625_bb1005","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117086","article-title":"Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis","volume":"238","author":"Sheikh","year":"2023","journal-title":"Environ. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb1010","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1021\/acsptsci.4c00493","article-title":"Eugenol-loaded lipid nanoparticles-derived hydrogels ameliorate psoriasis-like skin lesions by lowering oxidative stress and modulating inflammation","volume":"7","author":"Keshari","year":"2024","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb1015","doi-asserted-by":"crossref","first-page":"40228","DOI":"10.1021\/acsami.3c07582","article-title":"Cyclodextrin-coordinated liposome-in-gel for transcutaneous quercetin delivery for psoriasis treatment","volume":"15","author":"Zhang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2025.214625_bb1020","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.2147\/IJN.S165966","article-title":"Chitosan-based nanoformulated (–)-epigallocatechin-3-gallate (EGCG) modulates human keratinocyte-induced responses and alleviates imiquimod-induced murine psoriasiform dermatitis","volume":"13","author":"Chamcheu","year":"2018","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214625_bb1025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2017.03.385","article-title":"Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel","volume":"254","author":"Sun","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb1030","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.colsurfb.2017.10.029","article-title":"Skin-penetrating polymeric nanoparticles incorporated in silk fibroin hydrogel for topical delivery of curcumin to improve its therapeutic effect on psoriasis mouse model","volume":"160","author":"Mao","year":"2017","journal-title":"Colloids Surfaces B Biointerfaces."},{"key":"10.1016\/j.bioadv.2025.214625_bb1035","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2217\/nnm-2018-0345","article-title":"Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management","volume":"14","author":"Freag","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214625_bb1040","first-page":"1","article-title":"Topical application of Tetrandrine Nanoemulsion promotes the expansion of CD4+Foxp3+ regulatory T cells and alleviates Imiquimod-induced psoriasis in mice","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115823","article-title":"Preparation and characterization of solid lipid nanoparticles encapsulated noscapine and evaluation of its protective effects against imiquimod-induced psoriasis-like skin lesions","volume":"168","author":"Rahmanian-Devin","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioadv.2025.214625_bb1050","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.apsb.2021.07.019","article-title":"Enhanced uptake and anti-maturation effect of celastrol-loaded mannosylated liposomes on dendritic cells for psoriasis treatment","volume":"12","author":"Xi","year":"2022","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.bioadv.2025.214625_bb1055","first-page":"268","article-title":"Alantolactone-loaded chitosan \/ hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment, Asian","volume":"17","author":"Chen","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb1060","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jdv.16475","article-title":"Effective inhibition of Th17\/Th22 pathway in 2D and 3D human models of psoriasis by Celastrol enriched plant cell culture extract","volume":"34","author":"Nguyen","year":"2020","journal-title":"J. Eur. Acad. Dermatology Venereol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1065","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110352","article-title":"Loading of water-insoluble celastrol into niosome hydrogels for improved topical permeation and anti-psoriasis activity","volume":"182","author":"Meng","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214625_bb1070","article-title":"Liposomal emodin: a nanomedicine for two-photon imaging and mitochondria-targeted photodynamic therapy of psoriasis","volume":"325","author":"Sun","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214625_bb1075","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.29715","article-title":"CD44 assists the topical anti-psoriatic efficacy of curcumin-loaded hyaluronan-modified Ethosomes: a new strategy for clustering drug in inflammatory skin","volume":"9","author":"Zhang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bioadv.2025.214625_bb1080","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201903637","article-title":"Rekindling RNAi therapy: materials design requirements for in vivo siRNA delivery","volume":"31","author":"Kim","year":"2019","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioadv.2025.214625_bb1085","series-title":"Inhibition of keratin 17 expression with antisense and RNAi strategies: exploring novel therapy for psoriasis","first-page":"555","author":"Chang","year":"2011"},{"key":"10.1016\/j.bioadv.2025.214625_bb1090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejpb.2016.05.012","article-title":"RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase","volume":"105","author":"Depieri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214625_bb1095","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1166\/jbn.2016.2211","article-title":"Liquid crystalline nanodispersions functionalized with cell-penetrating peptides for topical delivery of short-interfering RNAs: a proposal for silencing a pro-inflammatory cytokine in cutaneous diseases","volume":"12","author":"Petrilli","year":"2016","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2021.08.039","article-title":"TNF\u03b1 siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy","author":"Suzuki","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb1105","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40259-018-0290-5","article-title":"Spherical nucleic acid nanoparticles: therapeutic potential","volume":"32","author":"Kapadia","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/j.bioadv.2025.214625_bb1110","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1021\/ja209351u","article-title":"Spherical nucleic acids","volume":"134","author":"Cutler","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioadv.2025.214625_bb1115","doi-asserted-by":"crossref","first-page":"7625","DOI":"10.1073\/pnas.1305804110","article-title":"Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb1120","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jid.2017.04.027","article-title":"Topically delivered tumor necrosis factor-\u03b1\u2013targeted gene regulation for psoriasis","volume":"137","author":"Lewandowski","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jid.2019.06.146","article-title":"Targeting the IL-17 receptor using liposomal spherical nucleic acids as topical therapy for psoriasis","volume":"140","author":"Liu","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/advs.202303706","article-title":"Transcutaneous immunotherapy for RNAi: a Cascade-responsive decomposable Nanocomplex based on polyphenol-mediated framework nucleic acid in psoriasis","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb1135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/s41467-019-09029-9","article-title":"Framework nucleic acids as programmable carrier for transdermal drug delivery","volume":"10","author":"Wiraja","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioadv.2025.214625_bb1140","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2147\/IJN.S441353","article-title":"Topical delivery of microRNA-125b by framework nucleic acids for psoriasis treatment","volume":"19","author":"Han","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214625_bb1145","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1346-8138.15149","article-title":"Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice","volume":"47","author":"Feng","year":"2020","journal-title":"J. Dermatol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1150","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.clim.2013.10.009","article-title":"Up-regulation of microRNA-210 induces immune dysfunction via targeting FOXP3 in CD4+ T cells of psoriasis vulgaris","volume":"150","author":"Zhao","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1155","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1172\/JCI97426","article-title":"MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation","volume":"128","author":"Wu","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bioadv.2025.214625_bb1160","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-020-00723-6","article-title":"Nanostructured lipid carrier co-delivering tacrolimus and TNF-\u03b1 siRNA as an innovate approach to psoriasis","author":"Viegas","year":"2020","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.bioadv.2025.214625_bb1165","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.2217\/nnm.13.202","article-title":"Topical administration of dual siRNAs using fusogenic lipid nanoparticles for treating psoriatic-like plaques","volume":"9","author":"Marepally","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214625_bb1170","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2016.05.017","article-title":"Novel amphiphilic lipid augments the co-delivery of erlotinib and IL36 siRNA into the skin for psoriasis treatment","volume":"246","author":"Boakye","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb1175","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2013.04.021","article-title":"Topical delivery of anti-TNF\u03b1 siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo","volume":"170","author":"Desai","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb1180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123019","article-title":"Liquid crystalline nanoparticles enable a multifunctional approach for topical psoriasis therapy by co-delivering triptolide and siRNAs","volume":"640","author":"Silvestrini","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214625_bb1185","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2019.04.002","article-title":"Oleic acid as the active agent and lipid matrix in cilomilast-loaded nanocarriers to assist PDE4 inhibition of activated neutrophils for mitigating psoriasis-like lesions","volume":"90","author":"Lin","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2025.214625_bb1190","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12951-020-00635-0","article-title":"Flexible liposomal gel dual-loaded with all-trans retinoic acid and betamethasone for enhanced therapeutic efficiency of psoriasis","volume":"18","author":"Wang","year":"2020","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.bioadv.2025.214625_bb1195","first-page":"1473","article-title":"Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis, nanomedicine nanotechnology","volume":"13","author":"Kaur","year":"2017","journal-title":"Biol. Med."},{"key":"10.1016\/j.bioadv.2025.214625_bb1200","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118819","article-title":"Chitosan\/hyaluronan nanogels co-delivering methotrexate and 5-aminolevulinic acid: a combined chemo-photodynamic therapy for psoriasis","volume":"277","author":"Wang","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.bioadv.2025.214625_bb1205","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.addr.2020.06.010","article-title":"Physical triggering strategies for drug delivery","volume":"158","author":"Sun","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb1210","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115055","article-title":"Long-acting microneedle formulations","volume":"201","author":"Vora","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioadv.2025.214625_bb1215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2025.113794","article-title":"Dissolving microneedles in transdermal drug delivery: a critical analysis of limitations and translation challenges","volume":"383","author":"Moawad","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb1220","doi-asserted-by":"crossref","first-page":"43588","DOI":"10.1021\/acsami.9b15668","article-title":"Hyaluronic acid-based dissolving microneedle patch loaded with methotrexate for improved treatment of psoriasis","volume":"11","author":"Du","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2025.214625_bb1225","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2024.02.009","article-title":"Substrate-free dissolving microneedles with barbed shape to increase adhesion and drug-delivery efficiency to skin","volume":"368","author":"Ren","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.bioadv.2025.214625_bb1230","doi-asserted-by":"crossref","first-page":"15162","DOI":"10.1021\/acsami.3c00058","article-title":"Supramolecular dissolving microneedle patch loading hydrophobic glucocorticoid for effective psoriasis treatment","volume":"15","author":"Wang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2025.214625_bb1235","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acsnano.2c08979","article-title":"Reactive oxygen species-responsive gel-based microneedle patches for prolonged and intelligent psoriasis management","volume":"17","author":"Bi","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.bioadv.2025.214625_bb1240","first-page":"1","article-title":"Microneedles with implantable tip-accumulated therapeutics for the long-term management of psoriasis","volume":"2405927","author":"Moawad","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.bioadv.2025.214625_bb1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138201","article-title":"Intradermal implantation of methotrexate-loaded puerarin-gelatin hydrogel via bubble-generating microneedles for psoriasis treatment","volume":"284","author":"Zhao","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1250","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1021\/acsbiomaterials.3c01810","article-title":"Efficient loading and sustained delivery of methotrexate using a tip-Swellable microneedle Array patch for psoriasis treatment","volume":"10","author":"Zhao","year":"2024","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.bioadv.2025.214625_bb1255","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123120","article-title":"An approach for psoriasis of microneedle patch simultaneously targeting multiple inflammatory cytokines and relapse related T cells","volume":"318","author":"Huang","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214625_bb1260","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121142","article-title":"Keratinocyte membrane-mediated nanodelivery system with dissolving microneedles for targeted therapy of skin diseases","volume":"278","author":"Jing","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214625_bb1265","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abe2888","article-title":"Microneedle-assisted genome editing: a transdermal strategy of targeting NLRP3 by CRISPR-Cas9 for synergistic therapy of inflammatory skin disorders","volume":"7","author":"Wan","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioadv.2025.214625_bb1270","doi-asserted-by":"crossref","DOI":"10.1016\/j.actbio.2025.04.015","article-title":"Drug-loaded microneedle patches containing regulatory T cell-derived exosomes for psoriasis treatment","author":"Ou","year":"2025","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioadv.2025.214625_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139210","article-title":"Dual-strategy microneedles of bio-oxygen therapy and artificial enzyme anti-oxidation for psoriasis treatment","volume":"291","author":"Wang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214625_bb1280","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1186\/s12951-024-02986-4","article-title":"Microneedle patches incorporating zinc-doped mesoporous silica nanoparticles loaded with betamethasone dipropionate for psoriasis treatment","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.bioadv.2025.214625_bb1285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202302314","article-title":"Regulating size and charge of liposomes in microneedles to enhance intracellular drug delivery efficiency in skin for psoriasis therapy","volume":"12","author":"Qu","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.bioadv.2025.214625_bb1290","first-page":"1","article-title":"Dual-action psoriasis therapy: Antiproliferative and immunomodulatory effects via self-locking microneedles","volume":"2409359","author":"Wang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.bioadv.2025.214625_bb1295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adfm.202205847","article-title":"Biologics-loaded Photothermally dissolvable hyaluronic acid microneedle patch for psoriasis treatment","volume":"32","author":"Wu","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioadv.2025.214625_bb1300","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.apsb.2020.08.008","article-title":"Layered dissolving microneedles as a need-based delivery system to simultaneously alleviate skin and joint lesions in psoriatic arthritis","volume":"11","author":"Yu","year":"2021","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825004522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825004522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:03:51Z","timestamp":1773849831000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825004522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":260,"alternative-id":["S2772950825004522"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214625","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating clinical challenges and nanotechnological based approaches for psoriasis therapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214625","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"214625"}}